About Indolands Pharma Private Limited
Data last updated:
Indolands Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC228266. Its GSTIN is 07AACCI7753B1ZQ (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Parminder Singh and Balvinder Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.220 Second Floor Vardhman Mall Sector – 19, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.62 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹62,565 (net margin 0.2%) and EBITDA of -₹1.22 Lakh (EBITDA margin -0.5%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years and 1% over five years.
The company is associated with 1 brand: Indolands Pharma. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indolandspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No.220 Second Floor Vardhman Mall Sector – 19, New Delhi, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Indolands Pharma Private Limited FY 2025 filings available
Indolands Pharma Private Limited reported revenue of ₹2.62 Cr (up 6% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Indolands Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 6% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Indolands Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹2.62 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.22 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹62,565 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Indolands Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indolands Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Indolands Pharma Private Limited
Indolands Pharma Private Limited is audited by G S S V & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G S S V & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Indolands Pharma Private Limited
Indolands Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parminder Singh | Director | 05 Dec 2011 | 14 Years 10 Months | Current |
| Balvinder Kaur | Director | 01 May 2024 | 2 Years 5 Months | Current |
Ownership and Shareholding of Indolands Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Indolands Pharma Private Limited
Indolands Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Indolands Pharma Private Limited
Indolands Pharma Private Limited has 1 court case on record: 1 filed by Indolands Pharma. All case is disposed. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Civil suit | Filed by the company against an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Indolands Pharma Private Limited
Indolands Pharma operates one associated brand: Indolands Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Marketing of pharmaceutical products, generic medicines, and related formulations in India and globally. | indolandspharma.com |
Employees and EPFO Compliance at Indolands Pharma Private Limited
Employment history and EPFO contributions of people linked to Indolands Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Indolands Pharma Private Limited
Indolands Pharma Private Limited has 6 board changes on record since 2011: 3 appointments and 3 cessations. The latest: Moussa Felix Macinanke ceased to be Director on 28 Jul 2025.
Credit Ratings, Litigation & Regulatory Alerts for Indolands Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indolands Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indolands Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Indolands Pharma Private Limited
Indolands Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCI7753B1ZQ | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indolands Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indolands Pharma Private Limited
Indolands Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 December 2011 (15+ years old) and is registered under CIN U24232DL2011PTC228266.
Indolands Pharma reported revenue of ₹2.62 Cr for FY 2021 (up 6% YoY).
Indolands Pharma has 2 current directors:
- Parminder Singh - Director
- Balvinder Kaur - Director
Indolands Pharma reported a net profit of ₹62,565 (net margin 0.2%) and EBITDA of -₹1.22 Lakh (EBITDA margin -0.5%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Indolands Pharma is 68% over three years and 1% over five years. In the latest year (FY 2021) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Indolands Pharma is 07AACCI7753B1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Indolands Pharma is U24232DL2011PTC228266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indolands Pharma has 1 court case on record: 1 filed by the company.
Indolands Pharma was incorporated on 05 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Moussa Felix Macinanke ceased to be Director on 28 Jul 2025. Balvinder Kaur ceased to be Additional Director on 29 Sep 2024. Balvinder Kaur was appointed as Director on 01 May 2024. Indolands Pharma has 6 board changes on record in total.